Prevalence of hepatitis-C virus (HCV) among thalassemia patients in Khuzestan province, southwest Iran

Pakistan Journal of Medical Sciences

Volumn 25, Issue 1, 2009, Pages 113-117

  Boroujerdnia, Mehri Ghafourian ^a   Assarehzadegan, Mohammad Ali ^a   Zandian, Khoda Morad ^a   Rodan, Morteza Haghirizadeh ^b  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shafa Hospital   (Iran)

Author keywords

Hepatitis C; Khuzestan; Prevalence; Thalassemia

Indexed keywords

RNA;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHILD; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE DURATION; FEMALE; HEALTH CENTER; HEPATITIS C VIRUS; HUMAN; IRAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RETROSPECTIVE STUDY; RNA ANALYSIS; SCHOOL CHILD; SCREENING; THALASSEMIA; TRANSFUSION; VIRUS INFECTION;

EID: 62549139247     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med 2005;8(2):84-90.
2. Albertl A, Benvegnu L. Management of hepatitis C. J Hepatol 2003;38 Suppl 1:S104-18.
3. Ardalan FA, Osquei MRF, Toosi MN, Irvanloo G. Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study. BMC Gastroenterology 2004;4:17.
4. Assarehzadegan MA, shakerinejad G, Amini A, Rezaee SAR. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis 2008;12(4):387-90.
5. Pham TN, MacParland SA Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 2004;78(11):5867-74.
6. Matar GM, Sharara HM, Abdelnour GE, Abdelnoor AM. Genotyping of Hepatitis C Virus Isolates from Lebanese Hemodialysis Patients by Reverse Transcription PCR and Restriction Fragment Length Polymorphism Analysis of 5' Noncoding Region. J Clin Microbiol 1996;34(10):2623-4.
7. Abdelnour GE, Matar GM, Sharara HM, Abdelnoor AM. Detection of Anti-Hepatitis C-Virus Antibodies and Hepatitis C-Virus RNA In Lebanese Hemodialy-sis Patients. Eur J Epidemiol 1997;13(8):863-7.
8. Mirmomem S, Alvian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MAJ et al. Epidemiology of Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infections in Patients with Beta-thalas-semia in Iran: A Multicenter Study. Arch Iranian Med 2006;9(4):319-23.
9. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and hemodialysis patients in North Iran, Rasht. J Viral Hepat 2002;9(5):390-2.
10. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassemic children in Shiraz, Iran. J Pediatr Child Health 2001;37(6):564.
11. Al-Fuzae L, Aboolbacker KC, Al-Saleh Q. Beta thalassemia major in Kuwait. J Trop Pediatr 1998;44(5):311-2.
12. Al-Mahroos FT, Ebrahim A. Prevalence of hepatitis B, hepatitis C and human immune deficiency virus markers among patients with hereditary hemolytic anaemias. Ann Trop Paediatr 1995;15(2):121-8.
13. Al-Kubaisy WA, Al-Naib KT, Habib MA. Seroprevalence of hepatitis C virus specific antibodies among Iraqi children with thalassaemia. East Mediterr Health J 2006;12(1-2):204-10.
14. El-Gohary A, Hassan A, Nooman Z. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 1995;59(2):155-61.
15. Jaiswal SP, Chitnis DS, Naik G, Artwani KK, Pandit CS, Salgia P, et al. Prevalence of anti-HCV antibodies in central India. Indian J Med Res 1996;104:177-81.
16. Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rezaee SAR. Prevalence of Hepatitis C and B Infection and HCV Genotypes among Hemodialysis patients in Khuzestan Province, southwest Iran. Saudi J Kidney Dis Transpl. In press.
17. Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi J Kidney Dis Transpl 2008;19(1):110-5.
18. Al-Kubaisy WA, Al-Naib KT, Habib MA. Prevalence of HCV/HIV co-infection among haemophilia patients in Baghdad. East Mediterr Health J 2006;12(3-4):264-9.
19. Abutaleb N. Notes on HCV-ELISA test results of the hemodialysis patients. Saudi J Kidney Dis Transpl 2008;19(5):817-9.
20. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988-1994. New Eng J Med 1999;341(8):556-62.
21. nd and 3rd-generation HCV ELISA and RIBA to detect HCV polymerase chain reaction-positive donations. Vox Sanguinis 1994;67(2):236-7.
22. Farma E, Boeri E, Bettini P, Repetto CM, McDermott J, Lillo FB, Varnier OE. Single-step PCR in molecular diagnosis of hepatitis C virus infection. J Clin Microbiol 1996;34(12):3171-4.
23. Lok ASF, Gunaratnam NI. Diagnosis of hepatitis C. Hepatology 1997;26(Suppl 1):48S-56S.